Sangamo Therapeutics, Inc. (SGMO)
0.492
-0.01
(-2.25%)
USD |
NASDAQ |
Dec 10, 15:39
Sangamo Therapeutics Market Cap: 165.56M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novavax, Inc. | 1.100B |
| Arcturus Therapeutics Holdings, Inc. | 213.95M |
| Pfizer Inc. | 146.58B |
| AIM ImmunoTech, Inc. | 1.116M |
| Protalix Biotherapeutics, Inc. | 145.96M |
Market Cap Related Metrics
| PS Ratio | 3.710 |
| Price to Book Value | 26.52 |
| Price | 0.492 |
| Earnings Yield | -90.00% |